Acorn Capital Advisors, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Acorn Capital Advisors, Llc disclosed 15 stock positions valued at approximately $366.46M as of quarter-end June 30, 2026. The largest holdings include CG ONCOLOGY INC, TREVI THERAPEUTICS INC, and CANDEL THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 15
- Portfolio Value
- $366.46M
Holdings by Sector
Acorn Capital Advisors, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | CGON | Healthcare | 21.94% | 1,131,500 | +999 | +0.09% | $80,393,115 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 10.92% | 2,144,844 | - | - | $40,001,341 |
| CANDEL THERAPEUTICS INC | CADL | Healthcare | 9.83% | 3,497,948 | - | - | $36,028,864 |
| PUMA BIOTECHNOLOGY INC | PBYI | Healthcare | 9.14% | 4,131,299 | - | - | $33,504,835 |
| BICARA THERAPEUTICS | BCAX | Other | 5.21% | 643,381 | -1 | -0.00% | $19,102,000 |
| ONKURE THERAPEUTICS INC | OKUR | Other | 3.53% | 2,839,674 | - | - | $12,948,913 |
| PROTARA THERAPEUTICS INC | TARA | Healthcare | 1.83% | 1,752,115 | - | - | $6,693,079 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 1.80% | 929,077 | +333,333 | +55.95% | $6,596,447 |
| LEONABIO, INC. | LONA | Other | 1.59% | 634,539 | - | - | $5,831,413 |
| VERASTEM INC | VSTM | Healthcare | 1.53% | 1,469,153 | - | - | $5,612,164 |
| WHITEHAWK THERAPEUTICS INC | AADI | Healthcare | 1.42% | 1,139,363 | - | - | $5,218,283 |
| Q32 BIO INC. | QTTB | Healthcare | 0.75% | 216,171 | -98,881 | -31.39% | $2,754,019 |
| JASPER THERAPEUTICS | JSPR | Healthcare | 0.16% | 1,438,159 | +26,667 | +1.89% | $604,027 |
| BIOATLA INC | BCAB | Healthcare | 0.12% | 108,126 | -5,298,219 | -98.00% | $447,645 |
| VYNE THERAPEUTICS INC | VYNE | Healthcare | 0.00% | 1,425 | - | - | $926 |
Showing 15 of 15 holdings in the latest reporting period.